BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Human chorionic gonadotropin
,
Lipitor
,
rs7903146
,
FOXP1
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cu; X
Summary
General Info
Curated Studies
Most Correlated Studies
Peripheral blood cell gene expression changes in response to radiation therapy.
Head and neck cancer HN17 and HN31 cells depleted of DICER and LINE-1 and treated wirh 5-Aza-dC
Melanoma 888-MEL cells after drug cessation treated with dabrafenib and trametinib
Melanoma A375 and 451Lu cells after drug cessation treated with dabrafenib and trametinib
Embryonic kidney HEK293T17 cells with SUZ12 knockdown for 48hr
Explore Curated Studies Results
Literature
Most Relevant Literature
Stability and fundamental properties of Cu x O1-x as optoelectronic functional materials.
Dual promotional effect of Cu x O clusters grown with atomic layer deposition on TiO2 for photocatal…
Generation of multi-valence Cu x O by reduction with activated semi-coke and their collaboration in …
Ultra-small dispersed Cu x O nanoparticles on graphene fibers for miniaturized electrochemical senso…
Self-Assembled Hierarchical Cu x O@C18H36O2 Nanoflakes for Superior Fenton-like Catalysis over a Wid…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Study of CU-20401
Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)
Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
a Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401
Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ